IndraLab
Statements
reach
"Following peripheral administration in a mouse model of neuroinflammation induced by LPS, HsTX1[R14A] readily crosses the blood–brain barrier (BBB) [24] to achieve microglial Kv1.3 blockade, with a substantial reduction in plasma and brain levels of cytokines, including TNF-α, interleukin 1β (IL-1β) and interleukin-6 (IL-6) [23, 25]."